ANGO stock forecast
Our latest prediction for AngioDynamics, Inc.'s stock price was made on the Aug. 11, 2020 when the stock price was at 9.13$.
In the short term (2weeks), ANGO's stock price should underperform the market by -1.29%. During that period the price should oscillate between -8.67% and +8.22%.
In the medium term (3months), ANGO's stock price should underperform the market by -6.31%. During that period the price should oscillate between -29.67% and +20.16%.Get email alerts
Create a solid portfolio with ANGO
About AngioDynamics, Inc.
AngioDynamics, Inc. engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage. thrombolytic, and venous products. The company was founded by Eamonn P. Hobbs in 1988 and is headquartered in Latham, NY.
At the moment the company generates 264M USD in revenues.
On its last earning announcement, the company reported a loss of -4.38$ per share.
The book value per share is 14.63$
Three months stock forecastAug. 11, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|